This sort of announcement does nothing for the company’s credibility imo.
’warmth’ isn’t even their study - and they’ve put it in a price sensitive document, and headline claim it supports Veyonda; unbelievable!!
this sort of comparison of survivals between totally different studies is completely invalid. 71% increased survival ? Seriously?
really poor stuff imo
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
Ann: New Independent Trial Data Supports Potential of Veyonda, page-6
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 11.5¢ | $6.819K | 59.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 659373 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 9423 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 659373 | 0.110 |
4 | 82523 | 0.105 |
6 | 130000 | 0.100 |
1 | 40000 | 0.099 |
1 | 25357 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 9423 | 2 |
0.120 | 99714 | 1 |
0.125 | 377492 | 5 |
0.130 | 255577 | 3 |
0.135 | 131304 | 4 |
Last trade - 11.28am 04/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |